Drug recall D-0165-2024
Product
AMOXICILLIN for Oral Suspension USP, 400MG/5ML, 100ML (when reconstituted), Manufactured In Canada By: TEVA CANA LIMITED, Toronto, Canada M1B 2K9; Manufactured For: TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454. NDC: 0093-4161-73
Reason for recall
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Lots and codes
Batch 35447184A
Recall details
- Recalling firm
- CARDINAL HEALTHCARE, Dublin, OH
- Quantity
- 3 units
- Distribution
- Nationwide USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- January 26, 2022
- Terminated
- September 29, 2024
Related products
- Amoxicillin – drug information
- NDC 0093-2264 Amoxicillin · Amoxicillin 875 mg/1 · Teva Pharmaceuticals USA, Inc.
- NDC 0093-2267 Amoxicillin · Amoxicillin 125 mg/1 · Teva Pharmaceuticals USA, Inc.
- NDC 0093-4155 Amoxicillin · Amoxicillin 250 mg/5mL · Teva Pharmaceuticals USA, Inc.
- NDC 0093-3107 Amoxicillin · Amoxicillin 250 mg/1 · Teva Pharmaceuticals USA, Inc.
- NDC 0093-4160 Amoxicillin · Amoxicillin 200 mg/5mL · Teva Pharmaceuticals USA, Inc.
- NDC 0093-2263 Amoxicillin · Amoxicillin 500 mg/1 · Teva Pharmaceuticals USA, Inc.
- NDC 0093-2268 Amoxicillin · Amoxicillin 250 mg/1 · Teva Pharmaceuticals USA, Inc.
- NDC 0093-4161 Amoxicillin · Amoxicillin 400 mg/5mL · Teva Pharmaceuticals USA, Inc.
- NDC 0093-3109 Amoxicillin · Amoxicillin 500 mg/1 · Teva Pharmaceuticals USA, Inc.